TNF and autoimmune disease: The first molecularly targeted drug was infliximab, a chimera antibody targeting tumor necrosis factor (TNF), followed by the development of various drugs targeting molecules such as IL-17, IL-12/IL-23, IL-6R, CD80/CD86, and Janus kinases (JAKs), which are now used for the treatment of a variety of autoimmune diseases (3).